Second degree AV block primary prevention: Difference between revisions
Jump to navigation
Jump to search
| (13 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
{{Second degree AV block}} | {{Second degree AV block}} | ||
{{CMG}}; {{AE}} | {{CMG}}; {{AE}} {{Sara.Zand}} | ||
==Overview== | ==Overview== | ||
Effective measures for [[primary prevention ]] of [[atrioventricular block]] include treatment of [[hypertension]] and maintenance of normal [[blood glucose]] levels. [[Atrioventricular]] (AV) block is a common reason for [[pacemaker]] implantation, and the number of [[pacemaker]] implantations is increasing. [[Atrioventricular block]] most commonly occurs in the absence of significant [[cardiac]] disease and is generally attributed to idiopathic [[fibrosis]] of the conduction system. By definition, the cause of that [[fibrosis]] remains unknown without [[primary prevention]] strategy. | |||
[[ | |||
==Primary prevention== | ==Primary prevention== | ||
* | * Effective measures for [[primary prevention ]] of [[atrioventricular block]] include treatment of [[hypertension]] and maintenance of normal [[blood glucose]] levels.<ref name="pmid31125096">{{cite journal |vauthors=Kerola T, Eranti A, Aro AL, Haukilahti MA, Holkeri A, Junttila MJ, Kenttä TV, Rissanen H, Vittinghoff E, Knekt P, Heliövaara M, Huikuri HV, Marcus GM |title=Risk Factors Associated With Atrioventricular Block |journal=JAMA Netw Open |volume=2 |issue=5 |pages=e194176 |date=May 2019 |pmid=31125096 |pmc=6632153 |doi=10.1001/jamanetworkopen.2019.4176 |url=}}</ref><ref name="pmid14237429">{{cite journal |vauthors=LEV M |title=ANATOMIC BASIS FOR ATRIOVENTRICULAR BLOCK |journal=Am. J. Med. |volume=37 |issue= |pages=742–8 |date=November 1964 |pmid=14237429 |doi=10.1016/0002-9343(64)90022-1 |url=}}</ref>. | ||
* | * [[Atrioventricular block]] most commonly occurs in the absence of significant [[cardiac]] disease and is generally attributed to idiopathic [[fibrosis]] of the conduction system. | ||
* By definition, the cause of that [[fibrosis]] remains unknown without [[primary prevention]] strategy. | |||
* | * [[Primary prevention]] of [[congenital]] [[complete heart block]] or [[second-degree AV block]] for [[women ]] with [[SLE]] include taking [[hydroxychloroquine]] prior to [[conception]].<ref name="pmid30137589">{{cite journal| author=Clowse MEB, Eudy AM, Kiernan E, Williams MR, Bermas B, Chakravarty E et al.| title=The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices. | journal=Rheumatology (Oxford) | year= 2018 | volume= 57 | issue= suppl_5 | pages= v9-v17 | pmid=30137589 | doi=10.1093/rheumatology/key141 | pmc=6099126 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30137589 }}</ref> | ||
* | |||
==References== | ==References== | ||
Latest revision as of 08:55, 24 July 2021
|
Second degree AV block Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Second degree AV block primary prevention On the Web |
|
American Roentgen Ray Society Images of Second degree AV block primary prevention |
|
Risk calculators and risk factors for Second degree AV block primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sara Zand, M.D.[2]
Overview
Effective measures for primary prevention of atrioventricular block include treatment of hypertension and maintenance of normal blood glucose levels. Atrioventricular (AV) block is a common reason for pacemaker implantation, and the number of pacemaker implantations is increasing. Atrioventricular block most commonly occurs in the absence of significant cardiac disease and is generally attributed to idiopathic fibrosis of the conduction system. By definition, the cause of that fibrosis remains unknown without primary prevention strategy.
Primary prevention
- Effective measures for primary prevention of atrioventricular block include treatment of hypertension and maintenance of normal blood glucose levels.[1][2].
- Atrioventricular block most commonly occurs in the absence of significant cardiac disease and is generally attributed to idiopathic fibrosis of the conduction system.
- By definition, the cause of that fibrosis remains unknown without primary prevention strategy.
- Primary prevention of congenital complete heart block or second-degree AV block for women with SLE include taking hydroxychloroquine prior to conception.[3]
References
- ↑ Kerola T, Eranti A, Aro AL, Haukilahti MA, Holkeri A, Junttila MJ, Kenttä TV, Rissanen H, Vittinghoff E, Knekt P, Heliövaara M, Huikuri HV, Marcus GM (May 2019). "Risk Factors Associated With Atrioventricular Block". JAMA Netw Open. 2 (5): e194176. doi:10.1001/jamanetworkopen.2019.4176. PMC 6632153 Check
|pmc=value (help). PMID 31125096. - ↑ LEV M (November 1964). "ANATOMIC BASIS FOR ATRIOVENTRICULAR BLOCK". Am. J. Med. 37: 742–8. doi:10.1016/0002-9343(64)90022-1. PMID 14237429.
- ↑ Clowse MEB, Eudy AM, Kiernan E, Williams MR, Bermas B, Chakravarty E; et al. (2018). "The prevention, screening and treatment of congenital heart block from neonatal lupus: a survey of provider practices". Rheumatology (Oxford). 57 (suppl_5): v9–v17. doi:10.1093/rheumatology/key141. PMC 6099126. PMID 30137589.